Document is current
Any future updates will be listed below
-
Authors
Yu, Tingting
Bai, Rushui https://orcid.org/0000-0002-1718-7233
Wang, Zeming
Qin, Yuting
Wang, Jingwei https://orcid.org/0000-0001-6508-934X
Wei, Yaohua
Zhao, Ruifang https://orcid.org/0000-0002-2735-2159
Nie, Guangjun https://orcid.org/0000-0001-5040-9793
Han, Bing https://orcid.org/0000-0003-4584-1092
- License Information
-
More Information
Article History
Received: 23 April 2024
Accepted: 6 December 2024
First Online: 30 December 2024
Competing interests
: T.Y., R.B., Z.W., Y.Q., R.Z., B.H., and G.N. are inventors on a filed provisional application for China patent No. 2024115617826 (“A composite butyrate nanoparticle and its synthesis strategy and application”) submitted by Peking University School of Stomatology and the National Center for Nanoscience and Technology that covers the synthesis strategy and potential therapeutic use of BuNP@Shellac for inflammatory bowel disease and osteoporosis treatment. T.Y., R.B., Z.W., Y.Q., R.Z., B.H., and G.N. declare no other competing interests. J.W. and Y.W. declare no competing interests.
